Spondyloarthropathies News

Consistent follow-up visits with the same physician and treatment with subcutaneous or IV drugs are associated with better patient-reported experiences among those with inflammatory arthritis, according to findings published in the Journal of Clinical Rheumatology.

The FDA has extended approval for ixekizumab injection 80 mg/mL to treat adults with ankylosing spondylitis – or radiographic axial spondyloarthritis - according to an Eli Lilly press release.

A U.S. District Court judge has ruled in favor of Amgen in its lawsuit against Novartis’ Sandoz, which claimed patent infringement on its biologic etanercept by the biosimilar, etanercept-szzs.

Adults with active ankylosing spondylitis despite treatment with a first TNF-inhibitor, as well as those with stable disease receiving an originator TNF inhibitor, should not be switched to a biosimilar, according to updated recommendations from the American College of Rheumatology published in Arthritis Care & Research.

Historians attribute Philip II of Macedon — father of Alexander the Great — as the source of the motto and political principle known as “divide and conquer.” As a ruling technique, the maxim worked, with Phillip ultimately ruling over most of classical Greece; a success that would be repeated with Julius Caesar and Napoleon Bonaparte in the centuries to follow.

HILTON HEAD, S.C. — In a duet session focused on spondyloarthritis, Grace Wright, MD, PhD, and Reeti Joshi, MD, detailed the differences between axial and peripheral disease and identified the various features of both in an effort to aid early diagnosis.

There have been nearly 1,100 measles cases in the United States in the first half of 2019 — more cases of measles than in any year since the disease was declared eliminated in the U.S. in 2000. As of July 25, 30 states have reported cases of measles, with outbreaks currently ongoing in five jurisdictions across the country.

Join me as I explore a case of fever and migratory inflammatory arthritis, then discuss the case with the double-boarded rheumatologist/infectious disease expert, Cassandra Calabrese, DO.

Mild TNF inhibitor tapering is about as efficacious as the standard dose treatment in achieving inactive disease in patients with axial spondyloarthritis, according to data published in Arthritis Research & Therapy.

The FDA has approved the fourth biosimilar to adalimumab, adalimumab-bwwd, for all eligible indications of the biologic product, according to a company press release.